Moderna Covid vaccine

Moderna says COVID-19 vaccine durable for at least six months

In a final analysis from its Phase 3, or final stage, clinical trial, Moderna's Covid vaccine showed 93 percent efficacy at six months following the second dose.

published on : 5th August 2021

EU agency approves Moderna Covid vaccine site in France

The EMA says these new approved sites are expected to result in an additional 1 to 2 million vials of Moderna’s coronavirus vaccine every month.

published on : 11th June 2021